M J Biopharm Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 13.01 Cr
- Company Age 37 Year, 6 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 89.62 Cr
- Revenue Growth 8.69%
- Profit Growth -27.31%
- Ebitda -26.76%
- Net Worth 9.47%
- Total Assets 10.76%
About M J Biopharm
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U29249MH1987PTC044458
- Company No.
044458
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 1987
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does M J Biopharm Private Limited offer?
M J Biopharm Private Limited offers a wide range of products and services, including Pharmaceutical Services, Biotechnology Services.
Who are the key members and board of directors at M J Biopharm?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Shah  | Managing Director | 03-Dec-1997 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhaval Vashi | Director | 22-Jun-2013 | Current |
Financial Performance of M J Biopharm.
M J Biopharm Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 8.69% increase. The company also saw a substantial fall in profitability, with a 27.31% decrease in profit. The company's net worth moved up by a moderate rise of 9.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M J Biopharm?
In 2017, M J Biopharm had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eris M. J. Biopharm Private LimitedAmol Shah is a mutual person
Camlin Fine Sciences LimitedAmol Shah is a mutual person
Fine Aroma Specialities Private LimitedAmol Shah is a mutual person
- Fine Fragrances Private Limited
Amol Shah is a mutual person
Fine Aromatics And Herbal Extracts Private LimitedAmol Shah is a mutual person
- M. J. Biopharm Private Limited
Amol Shah and Dhaval Vashi are mutual person
Charges (Loans)
₹0
₹89.62 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 51.12 Cr
- Abn Amro Bank N. V. : 33.00 Cr
- Export-Import Bank Of India : 5.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jan 2009 | Abn Amro Bank N. V. | ₹14.50 Cr | Satisfied |
| 25 Jun 2007 | Abn Amro Bank N. V. | ₹18.50 Cr | Satisfied |
| 17 Aug 2006 | Export-Import Bank Of India | ₹5.50 Cr | Satisfied |
| 28 May 2003 | Canara Bank | ₹3.50 M | Satisfied |
| 12 Mar 2001 | Canara Bank | ₹0.29 M | Satisfied |
How Many Employees Work at M J Biopharm?
M J Biopharm has a workforce of 264 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M J Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M J Biopharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
